Roflumilast: Clinical Trials

18 trials of Roflumilast, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 3 unknown, 2 not yet recruiting, 1 recruiting. 18 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 418Completed 12, Unknown 3, Not yet recruiting 2, Recruiting 1

Follow Roflumilast: new trials by email Literature Review of Roflumilast trials Research Report on Roflumilast

Trials (filtered) newest first · largest first

All 18 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparative Effectiveness of Roflumilast and Azithromycin in Reducing Exacerbations in Severe Chronic Obstructive Pulmonary Disease ( COPD ) Patients With Chronic Bronchitis Phenotype
Roflumilast Oral Tablet, Azithromycin 250 mg - Chronic Obstructive Pulmonary Disease With Exacerbation
Phase 4Not yet recruitingSidra Aziz702027-02-012026-08-31
An Open Label Trial to Evaluate Efficacy and Safety of Roflumilast 0.3% Cream for Chronic Plaque and Nail Psoriasis
Roflumilast 0.3% topical cream - Chronic Plaque Psoriasis, Nail Psoriasis
Phase 4RecruitingModern Research Associates, PLLC152026-09-152026-10-01
Utilization of a Microdevice for Psoriasis and Atopic Dermatitis
In situ cutaneous microdevice, Triamcinolone, 5-Fluorouracil - Psoriasis, Atopic Dermatitis
Phase 4Not yet recruitingUniversity of California, San Francisco102026-08-012026-06-03
Evaluation of the Efficacy and Safety of Oral Roflumilast Versus Intralesional Corticosteroids Injection (ILCs) in the Treatment of Alopecia Areata
Roflumilast, intralesional steroid - Alopecia, Alopecia Areata
Phase 4CompletedCairo University502025-01-122025-09-15
Visualization of Topical Zoryve vs. Vehicle Using Line Field Optical Coherence Tomography in Healthy Skin
Roflumilast, Vehicle (Roflumilast 0.3% vehicle cream) - Healthy Skin
Phase 4UnknownRao Dermatology32024-05-282024-06-03
Treatment of Chronic Hand Eczema With Oral Roflumilast (HERO)
Roflumilast 500 Mcg Oral Tablet, Placebo - Chronic Hand Eczema
Phase 4CompletedJacob Pontoppidan Thyssen412023-09-252026-08-06
Role of Roflumilast in Ulcerative Colitis
Roflumilast 500 MCG Oral Tablet [DALIRESP], amino salicylic acid - Ulcerative Colitis
Phase 4CompletedTanta University522023-02-012025-01-28
PDE-4 Inhibitor Roflumilast and GLP-1 Agonist Liraglutide in Polycystic Ovary Syndrome
metformin, liraglutide, roflumilast - PCOS, Obesity
Phase 4CompletedUniversity Medical Centre Ljubljana452014-03-012014-07-10
Strategy to Improve Adherence of Roflumilast
Roflumilast escalation dosage, Roflumilast conventional dosage - Chronic Obstructive Pulmonary Disease
Phase 4UnknownAsan Medical Center802013-12-012013-12-23
PDE-4 Inhibitor Roflumilast and Polycystic Ovary Syndrome
metformin, metformin and roflumilast - PCOS, Obesity
Phase 4CompletedUniversity Medical Centre Ljubljana362013-09-012014-01-22
Use of Roflumilast to Prevent Exacerbations in Fibrotic Sarcoidosis Patients (REFS)
Roflumilast, Placebo - Sarcoidosis
Phase 4UnknownUniversity of Cincinnati502013-04-012015-12-08
The Effectiveness of Roflumilast in Improving Mucociliary Clearance in Patients With COPD and Chronic Bronchitis
Roflumilast, Placebo - COPD, Chronic Bronchitis
Phase 4CompletedJohns Hopkins University122013-03-182017-07-27
Roflumilast on Markers of Bone Metabolism and Endothelial Function in COPD
Roflumilast - Chronic Obstructive Pulmonary Disease
Phase 4CompletedUniversity of Pittsburgh262013-02-012017-08-29
Roflumilast Safety Administered Once a Day on Alternate Days for Two Weeks Compared to the Usual Dosage Once Daily
Roflumilast alternated days, Roflumilast 500 mcg per day - Chronic Obstructive Pulmonary Disease (COPD)
Phase 4CompletedFundación Pública Andaluza Progreso y Salud1052012-07-012015-07-08
Effects of ROFLUMILAST on Subclinical Atherosclerosis in Chronic Obstructive Pulmonary Disease (COPD)
Roflumilast, Placebo - Chronic Obstructive Pulmonary Disease and Allied Conditions
Phase 4CompletedLudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology802012-05-012019-04-12
Evaluation With CT Scan of Possible Changes in Airways After Treatment With Daxas® in Severe Chronic Obstructive Pulmonary Disease Patients
Roflumilast, Placebo of Roflumilast, Functional Respiratory Imaging - Pulmonary Disease, Chronic Obstructive
Phase 4CompletedFLUIDDA nv412011-12-012013-09-19
Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)
Roflumilast, Placebo - COPD, COPD Exacerbation
Phase 4CompletedAstraZeneca23542011-09-302017-04-13
Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Combinations of Long-acting β2-agonists (LABA) and Inhaled Glucocorticosteroid (ICS)
Roflumilast, Placebo - Chronic Obstructive Pulmonary Disease
Phase 4CompletedAstraZeneca19452011-05-012016-12-13

Conditions studied

Pulmonary Disease, Chronic Obstructive (9)  ·  Lung Diseases (2)  ·  Obesity (2)  ·  Alopecia (1)  ·  Alopecia Areata (1)  ·  Bronchiectasis (1)  ·  Bronchitis, Chronic (1)  ·  Colitis, Ulcerative (1)  ·  Dermatitis, Atopic (1)  ·  Dyspnea (1)  ·  Emphysema (1)  ·  Fibrosis (1)  ·  Psoriasis (1)  ·  Respiration Disorders (1)  ·  Sarcoidosis (1)

Sponsors

AstraZeneca (2)  ·  University Medical Centre Ljubljana (2)  ·  Asan Medical Center (1)  ·  Cairo University (1)  ·  FLUIDDA nv (1)  ·  Fundación Pública Andaluza Progreso y Salud (1)  ·  Jacob Pontoppidan Thyssen (1)  ·  Johns Hopkins University (1)  ·  LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology (1)  ·  Modern Research Associates, PLLC (1)  ·  Rao Dermatology (1)  ·  Sidra Aziz (1)  ·  Tanta University (1)  ·  University of California, San Francisco (1)  ·  University of Cincinnati (1)

Countries

United States (6)  ·  Spain (3)  ·  Austria (2)  ·  Belgium (2)  ·  Canada (2)  ·  Denmark (2)  ·  Egypt (2)  ·  Italy (2)  ·  Russia (2)  ·  Slovenia (2)  ·  South Korea (2)  ·  Argentina (1)  ·  Australia (1)  ·  Brazil (1)  ·  Chile (1)

Top investigators

Andrej Janez, MD, PhD (2)  ·  Beth Laube, PhD (1)  ·  Gregorio Soto, M.D. (1)  ·  Jessica Bon Field, MD, MS (1)  ·  Lieven Bedert, MD (1)  ·  Nadia Hansel, MD MPH (1)  ·  Otto C Burghuber, M.D. (1)  ·  Raymond Cho, MD, PhD (1)  ·  Robert P Baughman, MD (1)

Results publications

PMID 29763572, PMID 22791991, PMID 25684586, PMID 26032655, PMID 27585384, PMID 28679611, PMID 29579254, PMID 29797235, PMID 31354255, PMID 32725799, PMID 34744427